Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyBiologicalProcessregulation of Rab protein signal transduction

DENND4A DENND3

3.06e-056302GO:0032483
HumanPhenoMicrospherophakia

LTBP2 FBN1

2.08e-054102HP:0030961
HumanPhenoIridodonesis

LTBP2 FBN1

3.46e-055102HP:0100693
HumanPhenoSpherophakia

LTBP2 FBN1

3.46e-055102HP:0034375
MousePhenoabnormal pericardium morphology

AKAP13 FBN1 RPGRIP1L PRMT7 RTEL1

1.70e-05225215MP:0000288
MousePhenopericardial effusion

AKAP13 FBN1 PRMT7 RTEL1

2.03e-05111214MP:0005312
MousePhenohemopericardium

FBN1 PRMT7 RTEL1

4.54e-0547213MP:0005244
MousePhenoeffusion

AKAP13 FBN1 PRMT7 RTEL1

6.96e-05152214MP:0021205
MousePhenoheart hemorrhage

FBN1 PRMT7 RTEL1

7.29e-0555213MP:0009698
MousePhenoabnormal ductus venosus valve topology

RPGRIP1L PRMT7

1.66e-0413212MP:0013878
MousePhenoabnormal coronary sinus connection

RPGRIP1L PRMT7

1.66e-0413212MP:0013975
MousePhenoabnormal inferior vena cava valve morphology

RPGRIP1L PRMT7

1.93e-0414212MP:0010490
MousePhenoabnormal vitelline vein connection

RPGRIP1L PRMT7

2.55e-0416212MP:0013859
MousePhenothoracoschisis

RPGRIP1L PRMT7

3.24e-0418212MP:0008923
MousePhenoabnormal coronary sinus morphology

RPGRIP1L PRMT7

3.24e-0418212MP:0010436
DomainTB

LTBP2 FBN1

4.87e-057292PF00683
Domain-

LTBP2 FBN1

6.48e-0582923.90.290.10
DomainTB

LTBP2 FBN1

8.32e-059292PS51364
DomainTB_dom

LTBP2 FBN1

8.32e-059292IPR017878
DomainuDENN

DENND4A DENND3

2.41e-0415292PF03456
DomainDENN

DENND4A DENND3

2.76e-0416292PF02141
DomainUDENN

DENND4A DENND3

2.76e-0416292PS50946
DomainDDENN

DENND4A DENND3

2.76e-0416292PS50947
DomaindDENN_dom

DENND4A DENND3

2.76e-0416292IPR005112
DomainuDENN_dom

DENND4A DENND3

2.76e-0416292IPR005113
DomaindDENN

DENND4A DENND3

2.76e-0416292PF03455
DomainDENN

DENND4A DENND3

2.76e-0416292SM00799
DomainDENN

DENND4A DENND3

2.76e-0416292PS50211
DomainDENN_dom

DENND4A DENND3

2.76e-0416292IPR001194
DomaindDENN

DENND4A DENND3

2.76e-0416292SM00801
Domain-

AKAP13 POTEA TRPA1 ANKRD50

5.55e-042482941.25.40.20
DomainAnkyrin_rpt-contain_dom

AKAP13 POTEA TRPA1 ANKRD50

6.07e-04254294IPR020683
DomainAnk_2

POTEA TRPA1 ANKRD50

4.41e-03215293PF12796
DomainAnk

POTEA TRPA1 ANKRD50

5.19e-03228293PF00023
DomainANK

POTEA TRPA1 ANKRD50

6.77e-03251293SM00248
DomainANK_REPEAT

POTEA TRPA1 ANKRD50

6.92e-03253293PS50088
DomainANK_REP_REGION

POTEA TRPA1 ANKRD50

7.00e-03254293PS50297
DomainAnkyrin_rpt

POTEA TRPA1 ANKRD50

7.62e-03262293IPR002110
DomainEGF_CA

LTBP2 FBN1

7.85e-0386292PF07645
DomainEGF_Ca-bd_CS

LTBP2 FBN1

9.89e-0397292IPR018097
DomainEGF_CA

LTBP2 FBN1

1.03e-0299292PS01187
DomainASX_HYDROXYL

LTBP2 FBN1

1.05e-02100292PS00010
DomainEGF-type_Asp/Asn_hydroxyl_site

LTBP2 FBN1

1.17e-02106292IPR000152
Pubmed

Induction of apoptosis and fibrillin 1 expression in human dermal endothelial cells by scleroderma sera containing anti-endothelial cell antibodies.

CASP3 FBN1

7.19e-07230216802364
Pubmed

Confocal microscopy demonstrates association of LTBP-2 in fibrillin-1 microfibrils and colocalisation with perlecan in the disc cell pericellular matrix.

LTBP2 FBN1

7.19e-07230224867584
Pubmed

LTBP-2 specifically interacts with the amino-terminal region of fibrillin-1 and competes with LTBP-1 for binding to this microfibrillar protein.

LTBP2 FBN1

2.16e-06330217293099
Pubmed

A novel role for the peptidyl-prolyl cis-trans isomerase Cyclophilin A in DNA-repair following replication fork stalling via the MRE11-RAD50-NBS1 complex.

RANBP9 CASP3 GTF2E1 AFTPH ANKRD50 PRMT7

2.73e-0647230638943005
Pubmed

Comparative immunolocalization of the elastin fiber-associated proteins fibrillin-1, LTBP-2, and MAGP-1 with components of the collagenous and proteoglycan matrix of the fetal human intervertebral disc.

LTBP2 FBN1

4.31e-06430221540769
Pubmed

Weill-Marchesani Syndrome

LTBP2 FBN1

4.31e-06430220301293
Pubmed

Deficiency of lysyl hydroxylase 2 in mice causes systemic endoplasmic reticulum stress leading to early embryonic lethality.

CASP3 PLOD2

7.18e-06530230905411
Pubmed

Exploring functional candidate genes for genetic association in german patients with pseudoexfoliation syndrome and pseudoexfoliation glaucoma.

LTBP2 FBN1

1.08e-05630219182256
Pubmed

N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.

CASP3 PPP1R2B GTF2E1 SDE2 AFTPH PRMT7 GOLGB1

1.17e-0593430733916271
Pubmed

Developmental expression of latent transforming growth factor beta binding protein 2 and its requirement early in mouse development.

LTBP2 FBN1

1.51e-05730210848613
Pubmed

p140Cap Controls Female Fertility in Mice Acting via Glutamatergic Afference on Hypothalamic Gonadotropin-Releasing Hormone Neurons.

CASP3 SLC17A7

1.51e-05730235237119
Pubmed

Maternal aldehyde elimination during pregnancy preserves the fetal genome.

CASP3 ALDH1B1

1.51e-05730225155611
Pubmed

The autism-associated protein CHD8 is required for cerebellar development and motor function.

CASP3 SLC17A7

2.58e-05930233826902
Pubmed

Top2b is involved in the formation of outer segment and synapse during late-stage photoreceptor differentiation by controlling key genes of photoreceptor transcriptional regulatory network.

CASP3 SLC17A7

2.58e-05930228370415
Pubmed

Reciprocal Connections Between Cortex and Thalamus Contribute to Retinal Axon Targeting to Dorsal Lateral Geniculate Nucleus.

CASP3 SLC17A7

2.58e-05930228334242
Pubmed

Dystrophin Is Required for the Proper Timing in Retinal Histogenesis: A Thorough Investigation on the mdx Mouse Model of Duchenne Muscular Dystrophy.

CASP3 SLC17A7

3.94e-051130232982660
Pubmed

The transcription factor Bhlhb4 is required for rod bipolar cell maturation.

CASP3 SLC17A7

3.94e-051130215363390
Pubmed

Collagen XIV is important for growth and structural integrity of the myocardium.

CASP3 PLOD2

4.72e-051230222906538
Pubmed

The F-box protein Fbw7 is required for cerebellar development.

CASP3 SLC17A7

5.58e-051330221827743
Pubmed

Aldehyde dehydrogenase activity is necessary for beta cell development and functionality in mice.

CASP3 ALDH1B1

6.50e-051430226518685
Pubmed

Deletion of CHD8 in cerebellar granule neuron progenitors leads to severe cerebellar hypoplasia, ataxia, and psychiatric behavior in mice.

CASP3 SLC17A7

6.50e-051430235231638
Pubmed

Selective disruption of trigeminal sensory neurogenesis and differentiation in a mouse model of 22q11.2 deletion syndrome.

CASP3 FBN1

7.50e-051530233722956
Pubmed

Early Deletion of Neurod1 Alters Neuronal Lineage Potential and Diminishes Neurogenesis in the Inner Ear.

CASP3 SLC17A7

7.50e-051530235252209
Pubmed

Dynamic regulation of the expression of neurotrophin receptors by Runx3.

CASP3 SLC17A7

7.50e-051530218385258
Pubmed

Excitatory neuronal CHD8 in the regulation of neocortical development and sensory-motor behaviors.

CASP3 SLC17A7

8.57e-051630233626347
Pubmed

Thalamo-cortical axons regulate the radial dispersion of neocortical GABAergic interneurons.

CASP3 SLC17A7

8.57e-051630227935475
Pubmed

Selective induction of neocortical GABAergic neurons by the PDK1-Akt pathway through activation of Mash1.

CASP3 SLC17A7

9.70e-051730219549840
Pubmed

Transcription factor short stature homeobox 2 is required for proper development of tropomyosin-related kinase B-expressing mechanosensory neurons.

CASP3 SLC17A7

9.70e-051730221543603
Pubmed

The BMP antagonist gremlin 1 contributes to the development of cortical excitatory neurons, motor balance and fear responses.

CASP3 SLC17A7

9.70e-051730234184027
Pubmed

The Ncoa7 locus regulates V-ATPase formation and function, neurodevelopment and behaviour.

CASP3 SLC17A7

1.09e-041830233340069
Pubmed

Fibronectin isoforms promote postnatal skeletal development.

CASP3 FBN1

1.09e-041830239159790
Pubmed

The E2A splice variant E47 regulates the differentiation of projection neurons via p57(KIP2) during cortical development.

CASP3 SLC17A7

1.09e-041830228939666
Pubmed

Distinct and Cooperative Functions for the Protocadherin-α, -β and -γ Clusters in Neuronal Survival and Axon Targeting.

CASP3 SLC17A7

1.22e-041930228066179
Pubmed

Tlx3 and Runx1 act in combination to coordinate the development of a cohort of nociceptors, thermoceptors, and pruriceptors.

SLC17A7 TRPA1

1.22e-041930222787056
Pubmed

Loss of Prdm12 during development, but not in mature nociceptors, causes defects in pain sensation.

CASP3 TRPA1

1.35e-042030233789102
Pubmed

KIF2A deficiency causes early-onset neurodegeneration.

CASP3 SLC17A7

1.50e-042130236343267
Pubmed

Primordial germ cell proliferation is impaired in Fused Toes mutant embryos.

CASP3 RPGRIP1L

1.64e-042230220969841
Pubmed

Transient neuronal populations are required to guide callosal axons: a role for semaphorin 3C.

CASP3 SLC17A7

1.80e-042330219859539
Pubmed

Axonal projections of mechanoreceptive dorsal root ganglion neurons depend on Ret.

CASP3 SLC17A7

1.80e-042330220534675
Pubmed

A high-throughput approach for measuring temporal changes in the interactome.

RANBP9 GTF2E1 ALDH1B1 ZZEF1 PLOD2 TARS1 USP19

1.93e-04145530722863883
Pubmed

Endothelial cell-derived GABA signaling modulates neuronal migration and postnatal behavior.

CASP3 SLC17A7

1.96e-042430229086765
Pubmed

A hierarchical NGF signaling cascade controls Ret-dependent and Ret-independent events during development of nonpeptidergic DRG neurons.

CASP3 TRPA1

1.96e-042430217553423
Pubmed

Dystroglycan Maintains Inner Limiting Membrane Integrity to Coordinate Retinal Development.

CASP3 SLC17A7

2.13e-042530228760865
Pubmed

Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.

AKAP13 DENND4A ANKRD50 ZZEF1 DENND3

2.17e-0465030538777146
Pubmed

Reduced mTORC1-signaling in progenitor cells leads to retinal lamination deficits.

CASP3 SLC17A7

2.31e-042630238546215
Pubmed

Endothelial cells regulate neural crest and second heart field morphogenesis.

CASP3 PLOD2

2.31e-042630224996922
Pubmed

ISL1 is necessary for auditory neuron development and contributes toward tonotopic organization.

CASP3 SLC17A7

2.68e-042830236074819
Pubmed

The c-Ski family member and transcriptional regulator Corl2/Skor2 promotes early differentiation of cerebellar Purkinje cells.

CASP3 GOLGB1

2.68e-042830224491816
Pubmed

MLL1 is essential for retinal neurogenesis and horizontal inner neuron integrity.

CASP3 SLC17A7

2.88e-042930230093671
Pubmed

SNX27-driven membrane localisation of OTULIN antagonises linear ubiquitination and NF-κB signalling activation.

RANBP9 AFTPH ANKRD50 PLOD2

3.01e-0437830434315543
Pubmed

Mesenchyme-derived vertebrate lonesome kinase controls lung organogenesis by altering the matrisome.

CASP3 PLOD2

3.51e-043230236920550
Pubmed

Functional significance of isoform diversification in the protocadherin gamma gene cluster.

CASP3 SLC17A7

3.97e-043430222884324
Pubmed

Neurog1 and Neurog2 coordinately regulate development of the olfactory system.

CASP3 SLC17A7

4.45e-043630222906231
Pubmed

O-fucosylation of thrombospondin type 1 repeats is essential for ECM remodeling and signaling during bone development.

CASP3 FBN1

4.45e-043630235167946
Pubmed

Adamts18 Deficiency Causes Spontaneous SMG Fibrogenesis in Adult Mice.

CASP3 FBN1

4.70e-043730234323105
Pubmed

Family-wide characterization of the DENN domain Rab GDP-GTP exchange factors.

DENND4A DENND3

4.70e-043730220937701
Pubmed

Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.

RPGRIP1L ANKRD50 TARS1 GOLGB1 USP19

4.93e-0477730535844135
Pubmed

The Fgf9-Nolz1-Wnt2 axis regulates morphogenesis of the lung.

CASP3 TTF1

4.96e-043830237497597
Pubmed

Fibrillin-2 is a key mediator of smooth muscle extracellular matrix homeostasis during mouse tracheal tubulogenesis.

CASP3 FBN1

5.50e-044030230578393
Pubmed

A differential developmental pattern of spinal interneuron apoptosis during synaptogenesis: insights from genetic analyses of the protocadherin-gamma gene cluster.

CASP3 SLC17A7

6.65e-044430219029045
Pubmed

A comparison of whole-genome shotgun-derived mouse chromosome 16 and the human genome.

NAV2 DENND4A GOLGB1

7.29e-0420530312040188
Pubmed

A human MAP kinase interactome.

RANBP9 NAV2 AKAP13 GOLGB1

7.74e-0448630420936779
Pubmed

A central chaperone-like role for 14-3-3 proteins in human cells.

NAV2 AKAP13 DENND4A AFTPH GOLGB1

7.83e-0486130536931259
Pubmed

SERBP1 Promotes Stress Granule Clearance by Regulating 26S Proteasome Activity and G3BP1 Ubiquitination and Protects Male Germ Cells from Thermostimuli Damage.

CASP3 ALDH1B1 PLOD2 TARS1 USP19

8.55e-0487830537223481
GeneFamilyGuanylate cyclase receptors|DENN/MADD domain containing

DENND4A DENND3

3.09e-0425192504
GeneFamilyAnkyrin repeat domain containing

POTEA TRPA1 ANKRD50

1.96e-03242193403
GeneFamilyWD repeat domain containing

DENND3 BRWD1

3.04e-02262192362
CoexpressionGSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_MAC_UP

AKAP13 GTF2E1 ALDH1B1 CHML BRWD1

2.72e-06196305M5256
CoexpressionONDER_CDH1_TARGETS_2_UP

NAV2 LTBP2 FBN1 TRPA1 PLOD2

1.02e-05257305M13867
CoexpressionSASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION

LTBP2 FBN1 PLOD2

2.56e-0550303M1259
CoexpressionSASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION

LTBP2 FBN1 PLOD2

2.88e-0552303MM1118
CoexpressionGSE3982_NKCELL_VS_TH2_UP

LTBP2 ZZEF1 DENND3 USP19

7.28e-05197304M5596
ToppCellSmart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

NAV2 FBN1 TRPA1 PLOD2

8.41e-06194304f44394c8a6f86483063f2f5722f003a8a0a70254
ToppCellControl_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type

NAV2 PLOD2 DENND3 GOLGB1

9.12e-0619830485f424cd9bb3117c9e322031024aabb87696ce47
ToppCellLPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

NAV2 PLOD2 DENND3 GOLGB1

9.49e-06200304ddfb1f006365bf16203ee49f20200f68220cc288
ToppCellILEUM-non-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

AKAP13 DENND3 GOLGB1

1.01e-04135303b7a792a7c0c22d8b703509f134115f0e394d7de0
ToppCellChildren_(3_yrs)-Mesenchymal-chondrocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor

LTBP2 FBN1 TRPA1

1.58e-04157303f147e24f2ece82e1c54750868954d09b3c461804
ToppCelltumor_Lymph_Node_/_Brain-B_lymphocytes-Undetermined|B_lymphocytes / Location, Cell class and cell subclass

RPGRIP1L USP19 TNIP3

2.14e-04174303390bd41ef114464f3db3e0cac4e67fe7571b4c23
ToppCell3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

NAV2 LTBP2 FBN1

2.17e-041753031799a7be623dc3bf53ba580a7c47d2619969d708
ToppCellControl-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

NAV2 PLOD2 DENND3

2.25e-041773039af14a056eb6d88c6f11b09f6d4c0d3448d647d5
ToppCellfacs-Brain_Myeloid-Striatum-24m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ALDH1B1 CHML TNIP3

2.25e-04177303f6b9d91d46830d0d207b0abd4ee5a4942fd99774
ToppCellBAL-Control-Myeloid-MoAM-MoAM2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

LTBP2 PLOD2 DENND3

2.36e-04180303dcec59d66995f701d816eaeea3ed1439a2f71b73
ToppCellBAL-Control-Myeloid-MoAM-MoAM2|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

LTBP2 PLOD2 DENND3

2.36e-04180303f3d8329b7e754c1ed89b0f39b8cd9e2ae22f6725
ToppCellControl-Myeloid-MoAM2|Control / Disease group,lineage and cell class （2021.01.30）

LTBP2 PLOD2 DENND3

2.36e-0418030338892483a6a5388765aec87f0119c0b9bb5c7cbd
ToppCellfacs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CASP3 ALDH1B1 PLOD2

2.40e-041813034e81ec1580e9acb22c32c465eb46f83d1e9e424e
ToppCellfacs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CASP3 ALDH1B1 PLOD2

2.40e-04181303ad30c01290fb98adbd0caed301a584761212c977
ToppCellfacs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CASP3 ALDH1B1 PLOD2

2.40e-041813033a3268a4dff8ffcb79e09f46490e138c96f8d916
ToppCell21-Trachea-Epithelial-Multiciliated_precursor|Trachea / Age, Tissue, Lineage and Cell class

RANBP9 RPGRIP1L PLOD2

2.44e-041823036e35892fa959ee31591850ded8f1088195ddeb01
ToppCellCOVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type

LTBP2 FBN1 TRPA1

2.44e-04182303fbd5e332df73bf7141c822fa67b76367dc962017
ToppCellFetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

NAV2 DENND3 TNIP3

2.52e-0418430329c95b814a0b1ad8734ed68b77df29c08594e5ec
ToppCellnormal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass

LTBP2 FBN1 PLOD2

2.52e-041843030b336489c10e8c3c957795dd845454f03404382b
ToppCellPCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

NAV2 LTBP2 FBN1

2.56e-041853037dcdc009c5681ee05dd18968f7e85c3403fe34af
ToppCellControl-Epithelial_alveolar|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

NAV2 PLOD2 DENND3

2.56e-041853033937e026add96a396122139daf8011cfbc60e75c
ToppCell5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

LTBP2 FBN1 PLOD2

2.56e-0418530387c416d14ca6255bee39b16e7571553e36ee3069
ToppCellPCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

NAV2 LTBP2 FBN1

2.64e-041873035258674d0346e5c51a4b965efcdc1790c970845d
ToppCellControl-Fibroblasts-Pathological_FB|Control / group, cell type (main and fine annotations)

LTBP2 FBN1 ALDH1B1

2.64e-04187303b7280b8baa0fba9c2b4bff660c240ed96f6ff9b7
ToppCellILEUM-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

AKAP13 CHML GOLGB1

2.64e-041873030099def970fbc828756fbf853eca2ce77b8cd342
ToppCellLA-01._Fibroblast_I|World / Chamber and Cluster_Paper

NAV2 LTBP2 FBN1

2.64e-041873034ea486991f66c29728d127171a07b81404ec0b78
ToppCellControl-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations)

NAV2 LTBP2 FBN1

2.64e-0418730392d468dde81125d51daf7abd4703741abe1ab91c
ToppCellfacs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NAV2 AKAP13 GOLGB1

2.68e-04188303a91443aa8fa8fa87f7501c59219daa0305bd0bbf
ToppCell3'_v3-GI_small-bowel|World / Manually curated celltypes from each tissue

AKAP13 GOLGB1 TNIP3

2.68e-04188303822c6abaf7bcd6721269bdbd1f2b286ccf0aec1a
ToppCellFibroblast-C|World / shred on cell class and cell subclass (v4)

LTBP2 FBN1 PLOD2

2.72e-0418930358e0400fbab5a0755504275aef5cf7986149abab
ToppCellILEUM-non-inflamed-(1)_T_cell-(1)_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

DENND4A GOLGB1 TNIP3

2.72e-041893032c8a2fb76ea002bac554bc1c761ce960b5e116e1
ToppCellPND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

LTBP2 FBN1 GOLGB1

2.77e-04190303d67e2814047c8df2ae4b7bc8be9539f5df6ecef2
ToppCellfacs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NAV2 AKAP13 GOLGB1

2.81e-041913033387b95a3f2445c672d407922fdce3a91eabaef8
ToppCellnucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

NAV2 LTBP2 FBN1

2.81e-041913036688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCellnucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

LTBP2 FBN1 PLOD2

2.85e-0419230367e845e513e76e820f55e2f0d15eb16f2944d05c
ToppCellnucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

NAV2 LTBP2 FBN1

2.85e-0419230399ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCellPND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

NAV2 PLOD2 DENND3

2.85e-04192303790282d4232311df3dac4ad97c80fc53443beccc
ToppCellPND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

NAV2 PLOD2 DENND3

2.85e-04192303b2d9bffccd6264b4f12d88a0780646ee0b41969f
ToppCellLA|World / Chamber and Cluster_Paper

NAV2 LTBP2 FBN1

2.90e-04193303d4bf89437216baf489ea0239136dcedf3b6714af
ToppCell368C-Lymphocytic-NK_cells-Proliferating_NK_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

FBN1 ALDH1B1 DENND3

2.90e-041933035f5904cec8b2967154ef2eab3c48f51df53aca4a
ToppCellMegakaryocytic-erythropoietic-Erythro-cells-Basophilic_Erythroblast|World / Lineage, cell class and subclass

FBN1 ALDH1B1 PLOD2

2.94e-04194303f054d78429364622d402ce1d9bf6ad13a1a1bf7e
ToppCellLA-02._Fibroblast_II|LA / Chamber and Cluster_Paper

NAV2 LTBP2 FBN1

2.94e-04194303234d1494c114cce77c619708bbcd8d5ce805f19b
ToppCellmoderate-Epithelial-FOXN4+|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

CASP3 RPGRIP1L PLOD2

2.94e-041943035dffa578149104dda33774361e9e77b227b5f1ce
ToppCellAdult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor

NAV2 LTBP2 FBN1

2.99e-0419530361c9e09fc84d1012e472185d70ad0a06cee30d6e
ToppCellCOVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations)

NAV2 LTBP2 FBN1

2.99e-04195303603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7
ToppCellCOVID-19-kidney-Fibroblast-2|COVID-19 / Disease (COVID-19 only), tissue and cell type

NAV2 FBN1 PLOD2

2.99e-041953033d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2
ToppCellLA-02._Fibroblast_II|World / Chamber and Cluster_Paper

NAV2 LTBP2 FBN1

2.99e-04195303a78b605b49acd8c9d68716266ca269dafcd910b9
ToppCellIPF-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class

LTBP2 FBN1 PLOD2

3.03e-041963037fc9894ceb79dab9f0495acc84e2d6d0d1c69bb7
ToppCellIPF-Stromal-Myofibroblast|IPF / Disease state, Lineage and Cell class

LTBP2 FBN1 PLOD2

3.03e-041963032d0a48e49b3b37bb66e33e74c52915911e1f8a74
ToppCellnucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

NAV2 LTBP2 FBN1

3.03e-041963037d8505dac15fa59935ccf592afc54b04c4c6554f
ToppCell10x3'2.3-week_17-19-Mesenchymal_adipo|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

NAV2 LTBP2 FBN1

3.08e-041973035afddde4e2b5cd55abe11e9b9efae02dbdc3da3a
ToppCellCOVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations)

LTBP2 FBN1 PLOD2

3.08e-04197303fb847f2277609c31fffcdf49517243ce0684facf
ToppCell10x3'2.3-week_17-19-Mesenchymal_adipo-stroma-adipo-CAR|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

NAV2 LTBP2 FBN1

3.08e-041973031baffd087ca194a7355fefbb3bf67befb14fe2de
ToppCellTracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

NAV2 LTBP2 FBN1

3.08e-041973030dd71e399f253787fa546a7e90c5373180b89ffd
ToppCell10x3'2.3-week_17-19-Mesenchymal_adipo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

NAV2 LTBP2 FBN1

3.08e-04197303b9745e382baa2725dfcae060701fb53f6c8a31fa
ToppCellAT2_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id

NAV2 ANKRD50 TNIP3

3.08e-041973035e0d222872a25bb9e9069d3dffda2844bb69874a
ToppCellCOVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations)

LTBP2 FBN1 PLOD2

3.08e-04197303f1c8936986123a3151140c374fcd62d6705c530b
ToppCellnucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

NAV2 LTBP2 FBN1

3.12e-041983038f52243ca8b9ba68a75ae411506a3a6de258eb97
ToppCell10x3'2.3-week_14-16-Mesenchymal_adipo-stroma-adipo-CAR|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

NAV2 LTBP2 FBN1

3.12e-04198303a8c21f4db6730d0aa05b61fbe72bf9f7571a9015
ToppCell10x3'2.3-week_14-16-Mesenchymal_adipo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

NAV2 LTBP2 FBN1

3.12e-041983038b68fc887e5ad0a59ea4d93dfd1edda67030f142
ToppCelltumor_Lung-Fibroblasts-Myofibroblasts|tumor_Lung / Location, Cell class and cell subclass

LTBP2 FBN1 PLOD2

3.12e-0419830331f9181dab689aabe9c6182c2ef7de65ba3f0ff6
ToppCellParenchymal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

LTBP2 FBN1 TRPA1

3.12e-04198303300d7cc56207d77168390fa1ffcbcf76767b1b80
ToppCell3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_4_(MMP1+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract

LTBP2 FBN1 PLOD2

3.12e-04198303229588189825b1080181db9515185677b742c668
ToppCellCOVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type

NAV2 LTBP2 FBN1

3.12e-04198303df3de77216f5c5d6141ec44d01c56b942f611838
ToppCell10x3'2.3-week_14-16-Mesenchymal_adipo|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

NAV2 LTBP2 FBN1

3.12e-041983034739b2e4ab141c66772e61686b45614a1839483e
ToppCellCOVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type

NAV2 LTBP2 FBN1

3.12e-041983033ec01a55ade5e1627258cc3cfebb2c3207a4cb43
ToppCellLPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

NAV2 DENND3 GOLGB1

3.17e-04199303d43c605a4ff221cf78d91678c15d2ad20f831c7f
ToppCellstromal_cell|World / Lineage and Cell class

NAV2 LTBP2 FBN1

3.17e-04199303507a82d0529b5b1fa5aebcfe43db53f0b6e3f8f0
ToppCellstromal_cell-stromal_cell|World / Lineage and Cell class

NAV2 LTBP2 FBN1

3.17e-0419930374262363a34da3a1eb55ab375fd61ddd7bb39b23
ToppCelldistal-3-mesenchymal-Myofibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

LTBP2 FBN1 TRPA1

3.17e-041993031f20addc0d138fec02ed6ca4c518169c568de263
ToppCellTracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

NAV2 LTBP2 FBN1

3.22e-04200303b4ccffdd79526c85e5273d27b668dbddcddba1ee
ToppCell367C-Fibroblasts-Fibroblast-B_(Myofibroblast)|367C / Donor, Lineage, Cell class and subclass (all cells)

LTBP2 FBN1 PLOD2

3.22e-04200303731e55070a7ff315091855bd88cda30e5a7e1a98
ToppCellTracheal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

LTBP2 FBN1 TRPA1

3.22e-042003038ab0051544ea32eb8b3f7f8ba7582deaf8bf26c0
ToppCellBrain_organoid-organoid_Tanaka_cellReport|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type.

FBN1 TARS1 GOLGB1

3.22e-04200303b0ba486b55be18a4236bd2644f02352651f4b1fe
ToppCell367C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|367C / Donor, Lineage, Cell class and subclass (all cells)

LTBP2 FBN1 PLOD2

3.22e-04200303082e718c1da3f4fdd33a001d15ad3ddb2be985c7
ToppCelldistal-mesenchymal-Myofibroblast-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

LTBP2 FBN1 TRPA1

3.22e-04200303069c8949b33ecfdb6da32992002d4060ff6082bc
ToppCellBronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

NAV2 LTBP2 FBN1

3.22e-04200303cae972324d1dfea6efeaf6013f265c7c6bb48db4
ToppCellTracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

NAV2 LTBP2 FBN1

3.22e-042003033dd022e974fec7013ba18f333da63f58fbf2dd7c
ToppCellTracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

NAV2 LTBP2 FBN1

3.22e-04200303c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b
ToppCelltumor_Lymph_Node_/_Brain-Fibroblasts-Myofibroblasts|Fibroblasts / Location, Cell class and cell subclass

LTBP2 FBN1 PLOD2

3.22e-04200303eabb7d4aa92ace7d970bcd3fae2c7cb5400a43b4
ToppCell(5)_Fibroblast-B_(Myofibroblast)|World / Lung cell shreds - cell class (v4) and cell subclass (v4)

LTBP2 FBN1 PLOD2

3.22e-042003039bbaa666d0f3b4782c1b4b95e0fa5fc1467842d8
ToppCellLPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type

NAV2 GOLGB1 TNIP3

3.22e-042003032dadf317a42a7e27cc1fac74f91b806c93a57108
ToppCellcellseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

LTBP2 FBN1 TRPA1

3.22e-04200303b441b3771fb7d9ee7b7a104afc35e466aace2da2
ToppCellBronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

NAV2 LTBP2 FBN1

3.22e-04200303e8462395fee0a532d1e7ec7f1795f28c42af6541
ToppCellTracheal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

NAV2 LTBP2 FBN1

3.22e-04200303a4ec0e80f5422b91b85264a9bb74568dd577e285
ToppCellTracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

NAV2 LTBP2 FBN1

3.22e-0420030358b38f9a484ee94191091a0659ed62ebed2d4a14
DrugHydrastine hydrochloride [5936-28-7]; Down 200; 9.6uM; MCF7; HT_HG-U133A

AKAP13 RPGRIP1L CHML RTEL1 USP19

4.51e-061962952889_DN
DrugChlorhexidine [55-56-1]; Down 200; 8uM; PC3; HT_HG-U133A

AKAP13 ALDH1B1 PRMT7 TTF1 RTEL1

4.74e-061982956302_DN
DrugValinomycin

CASP3 SLC17A7

7.00e-0510292ctd:D014634
Drug2,2,2,-trichloro-1-(3,4-dichlorophenyl)-ethylacetate

CASP3 TTF1

7.00e-0510292ctd:C530171
Drugborrelidin

CASP3 TARS1

8.55e-0511292ctd:C005066
DrugMyricetin [529-44-2]; Up 200; 12.6uM; HL60; HT_HG-U133A

CASP3 CHML PLOD2 BRWD1

8.73e-051862941334_UP
DrugEthynodiol diacetate [297-76-7]; Down 200; 10.4uM; MCF7; HT_HG-U133A

ALDH1B1 PRMT7 RTEL1 USP19

1.01e-041932945024_DN
DrugGabapentin [60142-96-3]; Up 200; 23.4uM; HL60; HT_HG-U133A

HSF2BP SLC17A7 CHML RTEL1

1.01e-041932942731_UP
DrugLynestrenol [52-76-6]; Down 200; 14uM; PC3; HT_HG-U133A

RPGRIP1L ALDH1B1 ZZEF1 DENND3

1.03e-041942946756_DN
DrugFluphenazine dihydrochloride [146-56-5]; Up 200; 7.8uM; PC3; HT_HG-U133A

SLC17A7 AKAP13 DENND4A DENND3

1.03e-041942945880_UP
Drug0179445-0000 [211246-22-9]; Down 200; 1uM; MCF7; HT_HG-U133A

CASP3 LTBP2 ZZEF1 RTEL1

1.03e-041942944758_DN
DrugOmeprazole [73590-58-6]; Up 200; 11.6uM; MCF7; HT_HG-U133A

SLC17A7 AKAP13 LTBP2 RTEL1

1.03e-041942944951_UP
DrugSuloctidil [54063-56-8]; Down 200; 11.8uM; MCF7; HT_HG-U133A

RPGRIP1L ALDH1B1 RTEL1 USP19

1.05e-041952945021_DN
DrugCromolyn disodium salt [15826-37-6]; Down 200; 7.8uM; PC3; HT_HG-U133A

AKAP13 DENND4A ALDH1B1 DENND3

1.07e-041962945754_DN
DrugPramoxine hydrochloride [637-58-1]; Down 200; 12.2uM; HL60; HT_HG-U133A

AKAP13 LTBP2 FBN1 ALDH1B1

1.07e-041962942198_DN
DrugDiflorasone Diacetate [33564-31-7]; Down 200; 8uM; MCF7; HT_HG-U133A

NAV2 AKAP13 RPGRIP1L ZZEF1

1.07e-041962942798_DN
DrugOleandomycin phosphate [7060-74-4]; Down 200; 5uM; MCF7; HT_HG-U133A

AKAP13 DENND4A ALDH1B1 RTEL1

1.09e-041972941518_DN
DrugChenodiol [474-25-9]; Down 200; 10.2uM; MCF7; HT_HG-U133A

AKAP13 DENND4A CHML BRWD1

1.09e-041972946012_DN
DrugAmpyrone [83-07-8]; Up 200; 19.6uM; MCF7; HT_HG-U133A

HSF2BP SLC17A7 LTBP2 ZZEF1

1.09e-041972942249_UP
DrugChlorphensin carbamate [886-74-8]; Down 200; 16.2uM; MCF7; HT_HG-U133A

CASP3 NAV2 LTBP2 ALDH1B1

1.09e-041972947472_DN
DrugMexiletine hydrochloride [5370-01-4]; Down 200; 18.6uM; HL60; HT_HG-U133A

AKAP13 ALDH1B1 PRMT7 USP19

1.11e-041982942364_DN
DrugNeostigmine bromide [114-80-7]; Up 200; 13.2uM; HL60; HT_HG-U133A

HSF2BP SLC17A7 RPGRIP1L ALDH1B1

1.11e-041982942432_UP
DrugAmrinone [60719-84-8]; Up 200; 21.4uM; MCF7; HT_HG-U133A

AKAP13 ZZEF1 RTEL1 USP19

1.11e-041982943465_UP
DrugHexamethonium dibromide dihydrate [55-97-0]; Down 200; 10uM; MCF7; HT_HG-U133A

AKAP13 CHML RTEL1 USP19

1.11e-041982941482_DN
DrugBenoxinate hydrochloride [5987-82-6]; Down 200; 11.6uM; HL60; HG-U133A

AKAP13 ALDH1B1 TTF1 DENND3

1.11e-041982941976_DN
DrugSulfapyridine [144-83-2]; Up 200; 16uM; PC3; HT_HG-U133A

DENND4A ALDH1B1 RTEL1 BRWD1

1.11e-041982947151_UP
DrugIoversol [87771-40-2]; Down 200; 5uM; PC3; HT_HG-U133A

HSF2BP AKAP13 RPGRIP1L USP19

1.11e-041982946726_DN
DrugNaftopidil dihydrochloride [57149-08-3]; Up 200; 8.6uM; PC3; HT_HG-U133A

HSF2BP SLC17A7 RPGRIP1L BRWD1

1.13e-041992944193_UP
DrugClindamycin hydrochloride [21462-39-5]; Up 200; 8.6uM; MCF7; HT_HG-U133A

CASP3 NAV2 DENND4A RTEL1

1.13e-041992947172_UP
DrugSulindac [38194-50-2]; Down 200; 11.2uM; PC3; HT_HG-U133A

AKAP13 RTEL1 DENND3 USP19

1.13e-041992941815_DN
Druggenistein; Up 200; 10uM; MCF7; HG-U133A

CASP3 NAV2 HSF2BP DENND3

1.13e-04199294638_UP
Drugperfosfamide

CASP3 ALDH1B1 TTF1

1.13e-0474293ctd:C011272
DrugTerazosin hydrochloride [63590-64-7]; Down 200; 9.4uM; PC3; HT_HG-U133A

RANBP9 DENND4A CHML TTF1

1.16e-042002945831_DN
Drugdibutyltin dichloride

CASP3 AKAP13

2.11e-0417292CID000012688
Drug4-AN

CASP3 FBN1

2.11e-0417292CID000001720
DrugAC1L73H3

CASP3 TNIP3

2.64e-0419292CID000354009
Drugdiethyldithiocarbamate

GTF2E1 ALDH1B1 TNIP3

2.85e-04101293CID000008987
DrugRiluzole

CASP3 SLC17A7

2.93e-0420292ctd:D019782
DrugGadolinium

CASP3 TRPA1

3.24e-0421292ctd:D005682
DrugRuthenium Red

CASP3 TRPA1

3.90e-0423292ctd:D012430
Drugbromotrimethyltin

CASP3 AKAP13

4.25e-0424292CID000014015
DrugAconitine

CASP3 TRPA1

4.61e-0425292ctd:D000157
Drug15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid

CASP3 FBN1

5.39e-0427292ctd:D019796
Drugthiram

TARS1 TNIP3

5.39e-0427292CID000005455
DrugMenthol

CASP3 TRPA1

5.80e-0428292ctd:D008610
Drugexcavatolide B

CASP3 HSF2BP

6.23e-0429292ctd:C574336
Drugcarvacrol

CASP3 TRPA1

6.23e-0429292ctd:C073316
Drugbafilomycin A1

CASP3 SLC17A7

8.57e-0434292ctd:C040929
DrugAC1L1JOI

FBN1 PRMT7

1.01e-0337292CID000005135
Drugallyl isothiocyanate

CASP3 TRPA1

1.01e-0337292ctd:C004471
Drugdisulfiram

CASP3 ALDH1B1 RTEL1

1.05e-03158293CID000003117
DrugExcitatory Amino Acid Agents

CASP3 SLC17A7

1.13e-0339292ctd:D018683
Drugdecylubiquinone

CASP3 GTF2E1

1.13e-0339292CID000002971
DrugNSC325611

CASP3 AKAP13

1.13e-0339292CID000003239
DrugDB04790

CASP3 RTEL1

1.19e-0340292CID005326924
Drugtazarotene

CASP3 TARS1

1.19e-0340292CID000005381
Drug1,3-butadiene

CASP3 TRPA1

1.25e-0341292ctd:C031763
DiseaseWeill-Marchesani syndrome

LTBP2 FBN1

3.00e-063302C0265313
DiseaseWeill-Marchesani Syndrome, Autosomal Dominant

LTBP2 FBN1

3.00e-063302C1869115
DiseaseWeill-Marchesani Syndrome, Autosomal Recessive

LTBP2 FBN1

3.00e-063302C1869114
DiseaseWeill-Marchesani syndrome

LTBP2 FBN1

5.99e-064302cv:C0265313
DiseaseWeill-Marchesani syndrome (is_implicated_in)

LTBP2 FBN1

5.99e-064302DOID:0050475 (is_implicated_in)
DiseaseMarfan Syndrome

LTBP2 FBN1

5.46e-0511302C0024796
DiseaseHepatitis

NAV2 ANKRD50

2.28e-0422302HP_0012115
Diseaseidiopathic pulmonary fibrosis

AKAP13 RTEL1

1.54e-0357302EFO_0000768

Protein segments in the cluster

PeptideGeneStartEntry
DIEKESEGQAPCMAH

TTF1

876

Q15361
AHLCMDSVKTSDDEV

AFTPH

366

Q6ULP2
ADADMEHAVEQCHEA

ALDH1B1

296

P30837
DHSCTMGDAEEAQID

AKAP13

1166

Q12802
DRGAEVDHCDKDGMT

ANKRD50

736

Q9ULJ7
MGCHLDHFEEVSKEA

DENND3

266

A2RUS2
GIETDSGVDDDMACH

CASP3

171

P42574
SGVDDDMACHKIPVE

CASP3

176

P42574
DDCVDKVDMDKSGEV

DENND4A

646

Q7Z401
TCMHTVSDKDGDKDE

CHML

186

P26374
LNGSSKHDHEMEDCD

RANBP9

581

Q96S59
ECEDIGVAHVDLADM

RPGRIP1L

1251

Q68CZ1
FSEKACDELVEEMEH

PLOD2

571

O00469
DCEGFDVHIMDDMIK

PRMT7

536

Q9NVM4
FHVTRDGKNCEDMDE

FBN1

561

P35555
ESEEQDREDGKCHKM

BRWD1

1826

Q9NSI6
DAAHMACVDVNECDD

LTBP2

1766

Q14767
DSCAELGESKEHMES

SDE2

296

Q6IQ49
DCDREVEEEMQKHGS

POTEA

336

Q6S8J7
EAHNVEKMCEESASF

RTEL1

251

Q9NZ71
FCHTEVEEDESAMPK

GTF2E1

156

P29083
DDAHIFCAMEQIEDE

TARS1

461

P26639
AAEEACRHMGTKEEF

HSF2BP

6

O75031
VCHVDVSDKAGDEMD

NAV2

861

Q8IVL1
EEMSEEKCGFVGHDQ

SLC17A7

501

Q9P2U7
DDCAKEEMAVAADAA

USP19

256

O94966
KMEIISETEDDDSHC

TRPA1

1071

O75762
MIAAESSTEHKECAE

TNIP3

11

Q96KP6
HSMMGDDEDACRDTE

PPP1R2B

76

Q6NXS1
DDHEMVNMEFTCDHC

ZZEF1

1821

O43149
AEVHPAGDTAKECME

GOLGB1

1701

Q14789